A meta-analysis of the efficacy of programmed cell death 1/its ligand inhibitors plus cytotoxic T-lymphocyte-associated antigen 4 inhibitors in non-small cell lung cancer

• 主要な著者: Li Lin (著者), Lu Xiao (著者), Lei Li (著者), Chen Chen (著者), Haorong Zhang (著者), Changyan Yu (著者), Lanfang Zhang (著者), Anhua Wei (著者), Wei Li (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Immune checkpoint inhibitors (ICIs), either as monotherapy or in combination with chemotherapy, have improved the therapeutic outcome for non-small cell lung cancer (NSCLC). However, the efficacy of combination therapies, such as programmed cell death 1(PD-1)/its ligand (PD-L1) and cytot...